News and publications

Patent fees in the Eurasian Patent Organization will be increased starting from 1 February 2025

The Eurasian Patent Organization will be raising the fees for several services starting from February 1, 2025. This adjustment is…

1 неделя ago

At the end of 2024

At the end of 2024, as the year comes to a close, it is time to reflect on the past…

1 месяц ago

The benefits of the Eurasian patent system: a single patent for multiple countries

In 1995, the Eurasian Patent Convention (EAPC) was established to create a unified patent space, simplifying and reducing the cost…

2 месяца ago

Patentica at APAA 2024

Olga Gribanova and Eduard Shablin of Patentica were in attendance at the 76th Asian Patent Attorneys Association Council Meeting (APAA…

2 месяца ago

Tracking deadlines is an essential aspect of patent prosecution

Dear colleagues, we would like to inform you about the weekends and holidays in 2025 that will impact the workflow…

2 месяца ago

October 24-26, 2024 | Patentica took part in AIPLA 2024 Annual Meeting

Maria Nilova and Nikolai Kovkov from Patentica recently participated in the AIPLA 2024 Annual Meeting at the Gaylord National Resort…

3 месяца ago

Patentica participated in the LES USA-Canada Annual Meeting | October 20-23, 2024

Maria Nilova and Nikolai Kovkov from Patentica recently took part in the LES USA-Canada Annual Meeting from October 20 to…

3 месяца ago

4,667 intellectual property infringements were identified in the EAEU in 2023

On October 9, a meeting of the Advisory Committee on Intellectual Property under the Board of the Eurasian Economic Commission…

3 месяца ago

Rospatent’s clarifications on the Statute on Fees as amended

The Russian Patent and Trademark Office has issued clarifications regarding some typical questions on the new Statute on Fees, effective…

4 месяца ago

Revocation of Patent RU 2421238 Related to Liraglutide Composition (Sun Pharmaceuticals Industries, Ltd (IN) v. Novo Nordisk A/S (DK))

Patentica’s patent attorneys, Victor Lisovenko and Ksenia Emelianova have successfully represented Sun Pharmaceuticals in opposing Novo Nordisk’s patent RU 2421238.…

4 месяца ago